CellaVision AB - Asset Resilience Ratio

Latest as of December 2022: -0.58%

CellaVision AB (CEVI) has an Asset Resilience Ratio of -0.58% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of CellaVision AB to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Skr-5.15 Million

≈ $-554.44K USD Cash + Short-term Investments

Total Assets

Skr891.75 Million

≈ $95.97 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2022)

This chart shows how CellaVision AB's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see CellaVision AB balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down CellaVision AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore CellaVision AB long-term investment allocation to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr-5.15 Million	-0.58%
Total Liquid Assets	Skr-5.15 Million	-0.58%

Asset Resilience Insights

Limited Liquidity: CellaVision AB maintains only -0.58% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

CellaVision AB Industry Peers by Asset Resilience Ratio

Compare CellaVision AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd SHE:002223	Medical Devices	0.84%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	34.37%
Stratec SE XETRA:SBS	Medical Devices	0.29%
Shinhung KO:004080	Medical Devices	4.17%
DRTECH Corporation KQ:214680	Medical Devices	5.18%
Novacyt PA:ALNOV	Medical Devices	0.02%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.48%

Annual Asset Resilience Ratio for CellaVision AB (2012–2022)

The table below shows the annual Asset Resilience Ratio data for CellaVision AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	-0.58%	Skr-5.15 Million ≈ $-554.44K	Skr891.75 Million ≈ $95.97 Million	+2.06pp
2021-12-31	-2.64%	Skr-21.79 Million ≈ $-2.34 Million	Skr825.21 Million ≈ $88.81 Million	-0.06pp
2020-12-31	-2.58%	Skr-17.25 Million ≈ $-1.86 Million	Skr668.02 Million ≈ $71.89 Million	+0.21pp
2019-12-31	-2.79%	Skr-17.93 Million ≈ $-1.93 Million	Skr641.71 Million ≈ $69.06 Million	-16.83pp
2013-12-31	14.03%	Skr26.47 Million ≈ $2.85 Million	Skr188.57 Million ≈ $20.29 Million	+13.86pp
2012-12-31	0.18%	Skr318.00K ≈ $34.22K	Skr178.56 Million ≈ $19.22 Million	--

pp = percentage points

About CellaVision AB

ST:CEVI Sweden Medical Devices

Market Cap

$418.90 Million

Skr3.89 Billion SEK

Market Cap Rank

#13275 Global

#212 in Sweden

Share Price

Skr163.20

Change (1 day)

-1.09%

52-Week Range

Skr118.40 - Skr188.40

All Time High

Skr478.48